Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease

Background. Chronic obstructive lung disease (COPD) is characterised by partially reversible usually progressive airflow limitation caused by inflammation and remodelling. Stromelysin-1 (MMP-3) has regulatory activity on other matrix-metalloproteinases. Altered MMP-3 activity has been described in d...

Full description

Bibliographic Details
Main Authors: P. Santus, F. Casanova, M.L. Biondi, F. Blasi, F. Di Marco, S. Centanni
Format: Article
Language:English
Published: PAGEPress Publications 2016-01-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/371